[Hypnotics--state of the science]

Nervenarzt. 2014 Jan;85(1):67-76. doi: 10.1007/s00115-013-3893-6.
[Article in German]

Abstract

This article provides an overview of the indications and effects of sleep-inducing drugs. Pharmacological treatment should only be considered in cases of insufficient response to non-pharmacological interventions. Benzodiazepines and benzodiazepine receptor agonists are indicated for the short-term treatment of acute insomnia. Due to the risk of tolerance and dependency, sedative antihistamines and antidepressants are widely used as long-term hypnotics. Other substances, including herbal compounds and melatonin have few side effects; however, the therapeutic efficacy is very limited. Currently, long-term data on the efficacy and tolerability of sleep-inducing substances are lacking. Specifically in cases of non-response to first line treatment, extended psychiatric and somatic evaluation and treatment of associated disorders are recommended.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Benzodiazepines / administration & dosage*
  • Evidence-Based Medicine
  • Humans
  • Hypnotics and Sedatives / administration & dosage*
  • Mental Disorders / complications
  • Mental Disorders / diagnosis*
  • Mental Disorders / drug therapy*
  • Plant Preparations / administration & dosage*
  • Sleep Initiation and Maintenance Disorders / complications
  • Sleep Initiation and Maintenance Disorders / diagnosis*
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Treatment Outcome

Substances

  • Hypnotics and Sedatives
  • Plant Preparations
  • Benzodiazepines